https://www.selleckchem.com/products/sbp-7455.html
According to the World Health Organization, more than 250 million people worldwide are chronically infected with the hepatitis B virus, and almost 800.000 patients die annually of mediated liver disorders. Therefore, adequate biological test systems are needed that could fully simulate the course of chronic hepatitis B virus infection, including in patients with hepatocellular carcinoma. In this study, we will assess the effectiveness of existing protocols for isolation and cultivation of primary cells derived from patients with hepato
Me gusta
Comentario
Compartir
